The 17th annual European Life Sciences CEO Forum will bring together 400 plus delegates to hear presentations and panel discussions from industry executives across Europe and North America. The discussions will include a panel on obesity and cardiometabolic diseases; advances in therapies for neurological disorders and the outlook for venture capital and private equity investment.
